Sökning: "somatic genomic alterations"
Visar resultat 1 - 5 av 17 avhandlingar innehållade orden somatic genomic alterations.
1. Comprehensive analysis of structural genomic alterations in cancer : Computational approaches for identifying cancer driver events
Sammanfattning : The transformation of a normal cell into a cancer cell involves the accumulation of somatic DNA alterations that confer growth and survival advantages. These genomic alterations can be different in terms of pattern and size, comprising single nucleotide variants (SNVs), small insertions or deletions (indels), structural variations (SVs) or foreign DNA insertions such as viral DNA. LÄS MER
2. Prognostic and Predictive Somatic Mutations in Colorectal Cancer
Sammanfattning : Colorectal cancer (CRC) is the third most incident and the second deadliest cancer worldwide. Even though CRC incidence is strongly correlated with age, it has been increasing in developing countries and younger individuals. LÄS MER
3. Statistical assessment of genomic variability in tumours and bacterial communities
Sammanfattning : Current high-throughput DNA sequencing technologies have the ability to generate large amounts of high-resolution genomic data. The high dimensionality in combination with the substantial levels of technical errors and biological variability typically present in the data make, however, the analysis challenging. LÄS MER
4. Characterizing the spectrum of somatic alterations in canine and human cancers
Sammanfattning : Cancers arise as a result of deleterious somatic alterations accumulating in the genome during the process of cell division. These alterations arise either via exposure to mutagens or due to errors occurring during DNA replication. LÄS MER
5. Genetic Characterization and Identification of Novel Treatment Targets in Anaplastic Thyroid Carcinoma
Sammanfattning : Anaplastic thyroid cancer (ATC) is a rare and highly aggressive thyroid malignancy, usually resistant to conventional therapeutic strategies. The prognosis of ATC is extremely poor with a median survival rate of 6 months. Current treatment therapy includes surgical resection in combination with external radiotherapy and chemotherapy. LÄS MER